2012 otc marketing breakthrough strategy（2012年场外营销突破战略）.docVIP

下载本文档

1
0
约9.52千字
约 9页
2017-09-05 发布于浙江
举报
版权申诉

2012 otc marketing breakthrough strategy（2012年场外营销突破战略）.doc

1、本文档共9页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

2012 otc marketing breakthrough strategy（2012年场外营销突破战略）

2012 otc marketing breakthrough strategy Currently, close to the end of 2011, the relevant pharmaceutical industry policy frequently introduced, such as the official website of the Ministry of Science jointly developed ten departments lt;lt;medical technology development, ‘second five’gt;gt; one of its priorities include the need to further increase investment in science and technology field of medicine. upcoming medical policy, as well as ‘bio-pharmaceutical industry,’ second five ‘gt;gt; and lt;lt;Medical Device Industry and Technology Development Plan 2011-2015gt;gt;, these national planning and policy are the new medical reform a clear signal to further deepen the State management of drug use and will further increase, while the second Chinese R amp; D drug development or attached great importance to these policies will be gradually reflected in the pharmaceutical industry marketing. As the leading national policy, the domestic market is gradually Otc occurrence of changes in the policy environment and market environment changes, simply relying on price competition in the market era has begun into the competitiveness of relying on the product itself, relying on brand competitiveness and rely on OTC marketing professional competitiveness up. The classification of drugs from the national point of view, the current drugs can be divided into basic and non-drug-based medicine, however, the production and distribution companies from the OTC view, the actual operation, the division of drug and non-tender for the tender drugs are more reasonable. Tender drugs, primarily based medicine with complementary varieties, tender sales have their own characteristics, which the government-led component is very large, rather than tender varieties in the current situation, mainly rely on market competition. then the dimension of OTC drugs can be from the business to be divided up: the operation of the tender varieties of OTC and OTC non-tender varieties of operation. The ope